ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Commercial Learning & Development, Associate Director at BridgeBio Pharma - ApplyBlast

Commercial Learning & Development, Associate Director

BridgeBio Pharma

3 days ago

San Francisco, California, United States

Hybrid

Full Time

Director

4 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate Director of Commercial Learning & Development at BridgeBio leads the design and delivery of training strategies for rare disease commercial launches, partnering with field sales, marketing, and medical teams to ensure alignment and compliance. This role involves translating complex scientific information into actionable training programs, managing cross-functional projects, and driving measurable improvements in field performance. The position requires deep expertise in biotech training, adult learning principles, and regulatory compliance to support high-impact product launches.

Responsibilities

Design and implement comprehensive training curricula for rare disease commercial launches
Partner with field sales and leadership to identify skill gaps and drive training results
Manage training content through MLR process ensuring compliance with regulations and policies

Skills

About BridgeBio Pharma

bridgebio.com

Headquarters

Palo Alto, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers driven by clear genetic causes. The company advances programs from target discovery through clinical development, combining human genetics and translational science with rigorous clinical trials to create targeted therapeutics. BridgeBio builds a diversified portfolio of wholly owned and partnered programs across multiple modalities and uses a venture‑style operating model to accelerate and de‑risk development. Its mission is to translate genetic insights into precision medicines for patients with high unmet medical need.